Umbilical Cord Blood Regulatory T Lymphocyte
Showing 1 - 25 of >10,000
Type1 Diabetes, Autoimmune Diabetes Trial in Changsha (Liraglutide, UCB-Treg, Insulin)
Recruiting
- Type1 Diabetes Mellitus
- Autoimmune Diabetes
- Liraglutide
- +2 more
-
Changsha, Hunan, ChinaInstitute of Metabolism and Endocrinology, Second Xiangya Hospit
Mar 24, 2021
Diabetes, Type 1 Trial in Changsha (Umbilical Cord Blood Regulatory T cells Therapy, Insulin)
Recruiting
- Diabetes Mellitus, Type 1
- Umbilical Cord Blood Regulatory T cells Therapy
- Insulin
-
Changsha, Hunan, ChinaInstitute of Metabolism and Endocrinology, Second Xiangya Hospit
Mar 24, 2021
Plasma Cell Leukemia, Plasma Cell Myeloma Trial in Houston (procedure, biological, other, drug)
Active, not recruiting
- Plasma Cell Leukemia
- Plasma Cell Myeloma
- Autologous Hematopoietic Stem Cell Transplantation
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- +8 more
- Biospecimen Collection
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 22, 2023
Diabetes, Type 1, Immunologic Deficiency Syndromes Trial in Shanghai (Sequential transplantation)
Recruiting
- Diabetes Mellitus, Type 1
- Immunologic Deficiency Syndromes
- Sequential transplantation
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Aug 4, 2022
Amyotrophic Lateral Sclerosis Trial in New York (CK0803, Excipient)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- CK0803
- Excipient
-
New York, New YorkColumbia University Irving Medical Center
Jan 26, 2023
Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus) Trial in Pessac, Paris (Human T Lymphoid Progenitor (HTLP)
Recruiting
- Acute Myeloid Leukemia (AML) or Minimal Residual Disease (MRD Plus)
- Human T Lymphoid Progenitor (HTLP) injection
-
Pessac, France
- +1 more
Oct 28, 2021
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in Aurora,
Completed
- Acute Biphenotypic Leukemia
- +6 more
- Cyclosporine
- +6 more
-
Aurora, Colorado
- +2 more
Jan 12, 2022
COVID19, ARDS Trial in United States (CK0802, Placebo)
Completed
- COVID19
- ARDS
- CK0802
- Placebo
-
Baltimore, Maryland
- +4 more
Mar 8, 2022
Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent
Available
- Hematologic Malignancies
- +2 more
- CliniMACS CD34 Reagent System
-
Durham, North CarolinaDuke University Medical Center
Nov 12, 2021
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)
Recruiting
- Acute Leukemia
- +24 more
- Fludarabine
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 4, 2021
Acute GVHD Trial in Kansas City (MSCTC-0010 Dose Escalation)
Recruiting
- Acute Graft Versus Host Disease
- MSCTC-0010 Dose Escalation
-
Kansas City, KansasKansas University Cancer Center
Jan 30, 2023
Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)
Terminated
- Acute Lymphoblastic Leukemia
- +17 more
- Infusion of Treg
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Sep 8, 2020
Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)
Completed
- Leukemia
- Lymphoma
- Rituximab
- +10 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 6, 2021
Acute Myelocytic Leukemia Trial in Hefei (Unrelated umbilical cord blood, Venetoclax, Decetabine)
Recruiting
- Acute Myelocytic Leukemia
- Unrelated umbilical cord blood
- +3 more
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Oct 27, 2023
MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)
Recruiting
- Myelodysplastic Syndromes
- Unrelated Umbilical Cord Blood
- +3 more
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Oct 27, 2023
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Umbilical Cord Abnormalities in Prediction of Adverse Pregnancy
Not yet recruiting
- Small for Gestational Age at Delivery
- +3 more
- Umbilical cord measurements & observations
- (no location specified)
Jun 5, 2023
Umbilical Cord Milking Trial in Alexandria (Delayed cord clamping for 30 seconds)
Completed
- Umbilical Cord Milking
- Delayed cord clamping for 30 seconds
-
Alexandria, EgyptTamer Ahmed Hosny
Jul 20, 2023
Severe Aplastic Anemia Trial in Hefei (Anti-Thymocyte Globulin (Rabbit))
Recruiting
- Severe Aplastic Anemia
- Anti-Thymocyte Globulin (Rabbit)
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of University of Science and Techn
Sep 9, 2023
Guillain-Barré Syndrome Trial (CK0801)
Withdrawn
- Guillain-Barré Syndrome
- CK0801
- (no location specified)
Jan 3, 2023
Three-dimensional Umbilical Cord Coiling Index
Not yet recruiting
- Umbilical Cord Issue
- +2 more
- Ultrasound
-
Nahariya, Hazafon, IsraelGalilee Medical Center
Feb 4, 2023
Ischemic Heart Disease Trial in Miami, Louisville, Houston (umbilical cord-derived mesenchymal stromal cells (UC-MSCs))
Not yet recruiting
- Ischemic Heart Disease
- umbilical cord-derived mesenchymal stromal cells (UC-MSCs)
-
Miami, Florida
- +2 more
Nov 17, 2023
Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Recombinant Interleukin-7
-
Houston, TexasM D Anderson Cancer Center
Jan 26, 2023